pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Apr 24·1 min read
save

Utah medical board urges halt to AI-driven prescription renewal pilot

Apr 24, 2026·read at STAT ↗RegulatoryNegative

Utah launched a pilot program that partners with AI startup Doctronic to let a chatbot conduct clinical evaluations and automatically renew prescriptions for roughly 200 medications, without direct physician oversight.

The state’s Medical Licensing Board said it only became aware of the agreement after the program began and raised concerns that the lack of physician involvement could endanger patients.

In a letter released Friday, the board asked state officials to suspend the experiment immediately, citing the need for proper consultation and safety safeguards.

The dispute highlights growing regulatory scrutiny of artificial-intelligence tools in health care and may affect how other jurisdictions approach similar AI prescription initiatives.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Utah medical board calls for immediate suspension of state’s AI doctor experiment”

read at STAT ↗
568 words · retrieved Apr 26
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Wearable Devices Ltd.2Wearable Devices Ltd.2ELI LILLY COLILLY
drugs
AmbienEdluarOzempicWegovy
topics
OncologyPsychiatry & CNS

related stories

  • Apr 25Nancy Cox, a CDC veteran and a stalwart in global flu research, dies at 77STAT
  • Apr 24Growing use of guest editors has turned some journals into a ‘playground of bad science’STAT
  • Aug 5Lilly confident in slow and steady Foundayo launch, as ex-US sales shineBioSpace
  • Apr 24Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelicsBioPharma Dive
  • Sep 16Novo explores macrocycles’ potential in $1.4B cardiometabolic pact with Danish biotechFierce Biotech